|Articles|December 3, 2008
Topical nepafenac as a treatment for CME
Topical nepafenac as a treatment for CME
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Macular laser picks up speed: The technology accelerating retinal therapies
2
FLORetina 2025: Long-term follow-up in paediatric gene therapy
3
FLORetina 2025: Enrico Borrelli on reframing retinal disease through the lens of choroidal health
4








































